Siokas, V.; Aloizou, A.-M.; Tsouris, Z.; Liampas, I.; Liakos, P.; Calina, D.; Docea, A.O.; Tsatsakis, A.; Bogdanos, D.P.; Hadjigeorgiou, G.M.;
et al. ADORA2A rs5760423 and CYP1A2 rs762551 Polymorphisms as Risk Factors for Parkinson’s Disease. J. Clin. Med. 2021, 10, 381.
https://doi.org/10.3390/jcm10030381
AMA Style
Siokas V, Aloizou A-M, Tsouris Z, Liampas I, Liakos P, Calina D, Docea AO, Tsatsakis A, Bogdanos DP, Hadjigeorgiou GM,
et al. ADORA2A rs5760423 and CYP1A2 rs762551 Polymorphisms as Risk Factors for Parkinson’s Disease. Journal of Clinical Medicine. 2021; 10(3):381.
https://doi.org/10.3390/jcm10030381
Chicago/Turabian Style
Siokas, Vasileios, Athina-Maria Aloizou, Zisis Tsouris, Ioannis Liampas, Panagiotis Liakos, Daniela Calina, Anca Oana Docea, Aristidis Tsatsakis, Dimitrios P. Bogdanos, Georgios M. Hadjigeorgiou,
and et al. 2021. "ADORA2A rs5760423 and CYP1A2 rs762551 Polymorphisms as Risk Factors for Parkinson’s Disease" Journal of Clinical Medicine 10, no. 3: 381.
https://doi.org/10.3390/jcm10030381
APA Style
Siokas, V., Aloizou, A.-M., Tsouris, Z., Liampas, I., Liakos, P., Calina, D., Docea, A. O., Tsatsakis, A., Bogdanos, D. P., Hadjigeorgiou, G. M., & Dardiotis, E.
(2021). ADORA2A rs5760423 and CYP1A2 rs762551 Polymorphisms as Risk Factors for Parkinson’s Disease. Journal of Clinical Medicine, 10(3), 381.
https://doi.org/10.3390/jcm10030381
